|
|
||||||||
Review article |


CNRS-UMR8161, Institut de Biologie de Lille, Institut Pasteur de Lille, 1 rue Calmette, BP447, 59021 Lille cedex, France
Correspondence
Jean Dubuisson
jean.dubuisson{at}ibl.fr
Several cellular molecules have been identified as putative receptors for Hepatitis C virus (HCV): CD81 tetraspanin, scavenger receptor class B type I (SR-BI), mannose-binding lectins DC-SIGN and L-SIGN, low-density lipoprotein receptor, heparan sulphate proteoglycans and the asialoglycoprotein receptor. Due to difficulties in propagating HCV in cell culture, most of these molecules have been identified by analysing their interaction with a soluble, truncated form of HCV glycoprotein E2. A recent major step in investigating HCV entry was the development of pseudoparticles (HCVpp), consisting of unmodified HCV envelope glycoproteins assembled onto retroviral core particles. This system has allowed the investigation of the role of candidate receptors in the early steps of the HCV life cycle and the data obtained can now be confirmed with the help of a newly developed cell-culture system that allows efficient amplification of HCV (HCVcc). Interestingly, CD81 and SR-BI have been shown to play direct roles in HCVpp and/or HCVcc entry. However, co-expression of CD81 and SR-BI in non-hepatic cell lines does not lead to HCVpp entry, indicating that other molecule(s), expressed only in hepatic cells, are necessary for HCV entry. In this review, the molecules that have been proposed as potential HCV receptors are described and the experimental data indicating that CD81 and SR-BI are potentially involved in HCV entry are presented.
Published online ahead of print on 14 February 2006 as DOI 10.1099/vir.0.81646-0.
These authors contributed equally to this review.
This article has been cited by other articles:
![]() |
A. K. Schwarz, J. Grove, K. Hu, C. J. Mee, P. Balfe, and J. A. McKeating Hepatoma Cell Density Promotes Claudin-1 and Scavenger Receptor BI Expression and Hepatitis C Virus Internalization J. Virol., December 1, 2009; 83(23): 12407 - 12414. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Charrin, S. Yalaoui, B. Bartosch, L. Cocquerel, J.-F. Franetich, C. Boucheix, D. Mazier, E. Rubinstein, and O. Silvie The Ig Domain Protein CD9P-1 Down-regulates CD81 Ability to Support Plasmodium yoelii Infection J. Biol. Chem., November 13, 2009; 284(46): 31572 - 31578. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Coffey, R. Rajapaksa, R. Liu, O. Sharpe, C.-C. Kuo, S. W. Krauss, Y. Sagi, R. E. Davis, L. M. Staudt, J. P. Sharman, et al. Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actin J. Cell Sci., September 1, 2009; 122(17): 3137 - 3144. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cukierman, L. Meertens, C. Bertaux, F. Kajumo, and T. Dragic Residues in a Highly Conserved Claudin-1 Motif Are Required for Hepatitis C Virus Entry and Mediate the Formation of Cell-Cell Contacts J. Virol., June 1, 2009; 83(11): 5477 - 5484. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Burlone and A. Budkowska Hepatitis C virus cell entry: role of lipoproteins and cellular receptors J. Gen. Virol., May 1, 2009; 90(5): 1055 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Arduise, T. Abache, L. Li, M. Billard, A. Chabanon, A. Ludwig, P. Mauduit, C. Boucheix, E. Rubinstein, and F. Le Naour Tetraspanins Regulate ADAM10-Mediated Cleavage of TNF-{alpha} and Epidermal Growth Factor J. Immunol., November 15, 2008; 181(10): 7002 - 7013. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Meunier, R. S. Russell, R. E. Engle, K. N. Faulk, R. H. Purcell, and S. U. Emerson Apolipoprotein C1 Association with Hepatitis C Virus J. Virol., October 1, 2008; 82(19): 9647 - 9656. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brazzoli, A. Bianchi, S. Filippini, A. Weiner, Q. Zhu, M. Pizza, and S. Crotta CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes J. Virol., September 1, 2008; 82(17): 8316 - 8329. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Espenel, E. Margeat, P. Dosset, C. Arduise, C. Le Grimellec, C. A. Royer, C. Boucheix, E. Rubinstein, and P.-E. Milhiet Single-molecule analysis of CD9 dynamics and partitioning reveals multiple modes of interaction in the tetraspanin web J. Cell Biol., August 25, 2008; 182(4): 765 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Machida, Y. Kondo, J. Y. Huang, Y.-C. Chen, K. T.-H. Cheng, Z. Keck, S. Foung, J. Dubuisson, V. M.-H. Sung, and M. M. C. Lai Hepatitis C Virus (HCV)-Induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope Protein J. Virol., July 1, 2008; 82(13): 6711 - 6720. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Harris, M. J. Farquhar, C. J. Mee, C. Davis, G. M. Reynolds, A. Jennings, K. Hu, F. Yuan, H. Deng, S. G. Hubscher, et al. CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry J. Virol., May 15, 2008; 82(10): 5007 - 5020. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jones and J. S Owen How does interferon inhibit HCV cell entry? Gut, May 1, 2008; 57(5): 573 - 574. [Full Text] [PDF] |
||||
![]() |
L. Meertens, C. Bertaux, L. Cukierman, E. Cormier, D. Lavillette, F.-L. Cosset, and T. Dragic The Tight Junction Proteins Claudin-1, -6, and -9 Are Entry Cofactors for Hepatitis C Virus J. Virol., April 1, 2008; 82(7): 3555 - 3560. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yang, C. Qiu, N. Biswas, J. Jin, S. C. Watkins, R. C. Montelaro, C. B. Coyne, and T. Wang Correlation of the Tight Junction-like Distribution of Claudin-1 to the Cellular Tropism of Hepatitis C Virus J. Biol. Chem., March 28, 2008; 283(13): 8643 - 8653. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Owsianka, A. W. Tarr, Z.-Y. Keck, T.-K. Li, J. Witteveldt, R. Adair, S. K. H. Foung, J. K. Ball, and A. H. Patel Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein J. Gen. Virol., March 1, 2008; 89(3): 653 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Mee, J. Grove, H. J. Harris, K. Hu, P. Balfe, and J. A. McKeating Effect of Cell Polarization on Hepatitis C Virus Entry J. Virol., January 1, 2008; 82(1): 461 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dreux, B. Boson, S. Ricard-Blum, J. Molle, D. Lavillette, B. Bartosch, E.-I. Pecheur, and F.-L. Cosset The Exchangeable Apolipoprotein ApoC-I Promotes Membrane Fusion of Hepatitis C Virus J. Biol. Chem., November 2, 2007; 282(44): 32357 - 32369. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. McCaffrey, I. Boo, P. Poumbourios, and H. E. Drummer Expression and Characterization of a Minimal Hepatitis C Virus Glycoprotein E2 Core Domain That Retains CD81 Binding J. Virol., September 1, 2007; 81(17): 9584 - 9590. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lavillette, E.-I. Pecheur, P. Donot, J. Fresquet, J. Molle, R. Corbau, M. Dreux, F. Penin, and F.-L. Cosset Characterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C Virus J. Virol., August 15, 2007; 81(16): 8752 - 8765. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Catanese, R. Graziani, T. von Hahn, M. Moreau, T. Huby, G. Paonessa, C. Santini, A. Luzzago, C. M. Rice, R. Cortese, et al. High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein J. Virol., August 1, 2007; 81(15): 8063 - 8071. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Helle, A. Goffard, V. Morel, G. Duverlie, J. McKeating, Z.-Y. Keck, S. Foung, F. Penin, J. Dubuisson, and C. Voisset The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein J. Virol., August 1, 2007; 81(15): 8101 - 8111. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Barsoum Hepatitis C virus: from entry to renal injury--facts and potentials Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1840 - 1848. [Full Text] [PDF] |
||||
![]() |
Z. Cai, L. Cai, J. Jiang, K.-S. Chang, D. R. van der Westhuyzen, and G. Luo Human Serum Amyloid A Protein Inhibits Hepatitis C Virus Entry into Cells J. Virol., June 1, 2007; 81(11): 6128 - 6133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Blanchet and C. Sureau Infectivity Determinants of the Hepatitis B Virus Pre-S Domain Are Confined to the N-Terminal 75 Amino Acid Residues J. Virol., June 1, 2007; 81(11): 5841 - 5849. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Tscherne, M. J. Evans, T. von Hahn, C. T. Jones, Z. Stamataki, J. A. McKeating, B. D. Lindenbach, and C. M. Rice Superinfection Exclusion in Cells Infected with Hepatitis C Virus J. Virol., April 15, 2007; 81(8): 3693 - 3703. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ciczora, N. Callens, F. Penin, E.-I. Pecheur, and J. Dubuisson Transmembrane Domains of Hepatitis C Virus Envelope Glycoproteins: Residues Involved in E1E2 Heterodimerization and Involvement of These Domains in Virus Entry J. Virol., March 1, 2007; 81(5): 2372 - 2381. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Koutsoudakis, E. Herrmann, S. Kallis, R. Bartenschlager, and T. Pietschmann The Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells J. Virol., January 15, 2007; 81(2): 588 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Krey, E. Moussay, H.-J. Thiel, and T. Rumenapf Role of the Low-Density Lipoprotein Receptor in Entry of Bovine Viral Diarrhea Virus J. Virol., November 1, 2006; 80(21): 10862 - 10867. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Helle, C. Wychowski, N. Vu-Dac, K. R. Gustafson, C. Voisset, and J. Dubuisson Cyanovirin-N Inhibits Hepatitis C Virus Entry by Binding to Envelope Protein Glycans J. Biol. Chem., September 1, 2006; 281(35): 25177 - 25183. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |